These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 19829282)
1. Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot study. Pellicano R; Strona S; Simondi D; Reggiani S; Pallavicino F; Sguazzini C; Bonagura AG; Rizzetto M; Astegiano M Minerva Gastroenterol Dietol; 2009 Sep; 55(3):227-35. PubMed ID: 19829282 [TBL] [Abstract][Full Text] [Related]
2. Can dietary integrators provide a clinical benefit in the treatment of functional dyspepsia? results from a prospective study with TUBES Gastro. Molteni M Minerva Gastroenterol Dietol; 2014 Jun; 60(2):105-12. PubMed ID: 24780944 [TBL] [Abstract][Full Text] [Related]
3. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out. Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243 [TBL] [Abstract][Full Text] [Related]
4. [Long-term course of reflux symptoms following Helicobacter pylori eradication]. Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Koskenpato J; Farkkilä M; Sipponen P Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319 [TBL] [Abstract][Full Text] [Related]
6. Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication--a 7-year follow-up study. Maconi G; Sainaghi M; Molteni M; Bosani M; Gallus S; Ricci G; Alvisi V; Porro GB Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):387-93. PubMed ID: 19182682 [TBL] [Abstract][Full Text] [Related]
7. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890 [TBL] [Abstract][Full Text] [Related]
8. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Kyzekové J; Arlt J; Arltová M Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Koskenpato J; Färkkilä M; Sipponen P Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090 [TBL] [Abstract][Full Text] [Related]
10. The effect of Helicobacter pylori eradication on dyspeptic symptoms, acid reflux and quality of life in patients with functional dyspepsia. Bektas M; Soykan I; Altan M; Alkan M; Ozden A Eur J Intern Med; 2009 Jul; 20(4):419-23. PubMed ID: 19524187 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083 [TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937 [TBL] [Abstract][Full Text] [Related]
13. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia. Tan HJ; Rizal AM; Rosmadi MY; Goh KL J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of quality of life in functional dyspepsia. Validation of a questionnaire and its use in clinical practice]. Buzás GM Orv Hetil; 2004 Mar; 145(13):687-92. PubMed ID: 15125319 [TBL] [Abstract][Full Text] [Related]
16. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD]. Onuchina EV; Brikova SI; Tsukanov VV Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379 [TBL] [Abstract][Full Text] [Related]
17. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting. Rosengren H; Polson RJ Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia. Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Elta GH; Scheiman JM; Barnett JL; Nostrant TT; Behler EM; Crause I; Appelman HD Am J Gastroenterol; 1995 Jul; 90(7):1089-93. PubMed ID: 7611203 [TBL] [Abstract][Full Text] [Related]
20. Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies. Kearney DJ; Avins AL; McQuaid KR Am J Gastroenterol; 2000 Sep; 95(9):2212-7. PubMed ID: 11007220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]